BriaCell Therapeutics (STU:8BT) FFO


STU:8BT BriaCell Therapeutics Corp STU:8BT
23 GF Score
Price €5.56
! 2 Warning Signs
View Full Analysis

What is BriaCell Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

STU:8BT
23GF Score
BriaCell Therapeutics Corp STU:8BT
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BriaCell Therapeutics Business Description

Address 235-15th Street, Suite 300, 3rd Floor, Bellevue Centre, West Vancouver, Vancouver, BC, CAN, V7T 2X1
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
23GF Score

Get the complete analysis for STU:8BT

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.56
Price